CDC team supports BioNTech / Pfizer support for the elderly and vulnerable

This letter: A Way to Start Again

Biden’s management plan for the well-known Covid-19 program was disrupted Thursday as a team of scientists advised the medical council to offer a third chance only to the elderly, residents and caregivers. .

The U.S. Centers for Disease Control and Prevention Vaccination Committee voted unanimously to recommend the BioNTech / Pfizer vaccine for people over the age of 65 and their caregivers, as well as for the 13-2 acceptance of incentives for people aged 50-64. .

The committee voted 9-6 to provide encouragement to people over the age of 18 with health problems. However, he refused to accept a third jab for those working at high risk of being found with Covid, in a 9-6 vote.

Biden officials plan to launch a common program for all Americans over the age of 16 from next week, even if regulators do not issue a permit. This angered some scientists, which caused it retirement of the two top FDA executives earlier this month.

The FDA advisory team later refused to accept BioNTech / Pfizer recommendations for anyone over the age of 16, instead promoting a smaller group for older and vulnerable groups. The FDA complied with the directive on Wednesday, acceptance a third level of people aged 65 and over and older people who are at high risk of Covid-19 or whose activities mean they are more likely to be infected.

The CDC group recommended minimum qualifications when asked by some members if the need for a particular measure exceeds the potential risks, especially for young people.

Several scientists were skeptical of how to encourage only those who received the BioNTech / Pfizer vaccine and expressed frustration over the lack of information on the Johnson & Johnson vaccine supplement.

“I do not understand how we can say to people 65 years of age or older that ‘you are at high risk of hospitalization… But only half of you can protect yourself right now’,” said Sarah Long, a professor of pediatrics at Drexel University College of Medicine.

The scientists also said that the most important thing is still a complete vaccine, called two weeks after the second dose of mRNA jab, such as those produced by BioNTech / Pfizer and Moderna, or a single shot by J&J. The FDA has already ordered a third mRNA vaccine for humans who have a weakened immune system.

Some members are skeptical of the amount of content available. Camille Kotton, an infectious disease specialist at Massachusetts General Hospital, said black and Latino people under the age of 65 had the highest number and needed more to show color. “It’s not the same effect in all races,” he said.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *